Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes

Shannon N. Edd, Javier Castañeda, Pratik Choudhary, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Charles Thivolet, Mark Evans, Roseline Ré, Jessica Cellot, Simona de Portu, Linda Vorrink, John Shin, Tim van den Heuvel, Ohad Cohen, Unknown

Open source

DOI: 10.1111/dom.15217
Published: 2023-08-08
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.15217,
  title = {Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes},
  author = {Shannon N. Edd and Javier Castañeda and Pratik Choudhary and Ralf Kolassa and Winfried Keuthage and Jens Kroeger and Charles Thivolet and Mark Evans and Roseline Ré and Jessica Cellot and Simona de Portu and Linda Vorrink and John Shin and Tim van den Heuvel and Ohad Cohen and Unknown},
  year = {2023},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.15217},
  url = {https://doi.org/10.1111/dom.15217}
}

RIS

TY  - JOUR
TI  - Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes
AU  - Shannon N. Edd
AU  - Javier Castañeda
AU  - Pratik Choudhary
AU  - Ralf Kolassa
AU  - Winfried Keuthage
AU  - Jens Kroeger
AU  - Charles Thivolet
AU  - Mark Evans
AU  - Roseline Ré
AU  - Jessica Cellot
AU  - Simona de Portu
AU  - Linda Vorrink
AU  - John Shin
AU  - Tim van den Heuvel
AU  - Ohad Cohen
AU  - Unknown
PY  - 2023
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.15217
UR  - https://doi.org/10.1111/dom.15217
ER  -

APA

Edd, S. N., Castañeda, J., Choudhary, P., Kolassa, R., Keuthage, W., Kroeger, J., Thivolet, C., Evans, M., Ré, R., Cellot, J., Portu, S. D., Vorrink, L., Shin, J., Heuvel, T. V. D., Cohen, O., & Unknown (2023). Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15217

Source records

crossref · retrieved 2026-09-26T06:21:04.245Z